Ostasin

Ostasin is a brand name for strontium ranelate, a medication used to treat postmenopausal osteoporosis. Osteoporosis is a condition characterized by weakened bones, making them more susceptible to fractures. Strontium ranelate works by both increasing bone formation and decreasing bone resorption, which are the processes by which bone is built and broken down, respectively. This dual action helps to improve bone density and reduce the risk of fractures.

The active ingredient, strontium ranelate, is a salt composed of strontium and ranelic acid. Strontium is a naturally occurring mineral that is chemically similar to calcium and can be incorporated into the bone matrix. Ranelic acid is an organic compound that facilitates the absorption and action of strontium. Ostasin is typically taken orally in a powder form that is dissolved in water.

Clinical trials have demonstrated that strontium ranelate can significantly reduce the risk of vertebral and non-vertebral fractures in postmenopausal women with osteoporosis. It is usually prescribed for women who are at high risk of fracture and for whom other osteoporosis treatments are not suitable. Side effects can include nausea, diarrhea, and skin reactions. In some cases, more serious side effects such as blood clots have been reported, leading to restrictions on its use in certain regions. The use of Ostasin requires careful consideration of its benefits and risks, and it should be taken under the supervision of a healthcare professional.